Decreased clearance of low-density lipoprotein in patients with chronic renal failure.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Kidney International

• Publication date

  1994-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/KI.1994.73PMID 8164446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors modulating the interaction of LDL with an arterial lipoprotein complexing proteoglycan: the effect of HDL.

  2009cited by this paper
• Modified forms of low density lipoprotein and atherosclerosis.

  1993cited by this paper
• Catabolism of low-density lipoprotein is altered in experimental chronic renal failure.

  1993cited by this paper
• Carbamylation-induced alterations in low-density lipoprotein metabolism.

  1992cited by this paper
• Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Hemodialysis Patients

  1992cited by this paper
• Decreased low-density lipoprotein receptor function and mRNA levels in lymphocytes from uremic patients.

  1992cited by this paper
• Lipid and lipoprotein (a) concentrations in renal transplant patients.

  1992cited by this paper
• High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.

  1992cited by this paper
• Lipid and lipoprotein (a) concentrations in renal ransplant patients

  1992cited by this paper
• Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.

  1991cited by this paper
• Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.

  1990cited by this paper
• Influence of end-stage renal failure on concentrations of free apolipoprotein A-1 in serum.

  1989cited by this paper
• Apolipoprotein B turnover in dialysis patients: its relationship to pathogenesis of hyperlipidemia.

  1989cited by this paper
• Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis.

  1989cited by this paper
• Quantitative and qualitative changes of apolipoprotein AI-containing lipoproteins in patients on continuous ambulatory peritoneal dialysis.

  1989cited by this paper
• Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-I.

  1988cited by this paper
• Lipoprotein abnormalities in chronic haemodialysis patients.

  1988cited by this paper
• Defect in cholesteryl ester transport in serum of patients with uremia receiving maintenance hemodialysis: increased inhibitor activity for cholesteryl ester transfer.

  1988cited by this paper
• Lipoproteins and apolipoproteins during the progression of chronic renal disease.

  1988cited by this paper
• The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells.

  1988cited by this paper
• Biochemistry and Clinical Significance of Lipoprotein (a)

  1988cited by this paper
• Regulation of low-density lipoprotein apolipoprotein B levels.

  1987cited by this paper
• Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

  1987cited by this paper
• Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.

  1987cited by this paper
• Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients.

  1987cited by this paper
• Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapy

  1987cited by this paper
• Lp(a) lipoprotein as a risk factor for myocardial infarction.

  1986cited by this paper
• Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

  1986cited by this paper
• Abnormal cell-interactive properties of low-density lipoproteins isolated from patients with chronic renal failure.

  1985cited by this paper
• Defect in cholesterol transport in patients receiving maintenance hemodialysis.

  1985cited by this paper
• Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.

  1985cited by this paper
• Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.

  1984cited by this paper
• Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia.

  1984cited by this paper
• Lipoproteins and atherosclerosis. A look back and a look ahead.

  1983cited by this paper
• Quantitative importance of different organs for cholesterol synthesis and low-density-lipoprotein degradation.

  1983cited by this paper
• 99mTc-DTPA--a useful clinical tool for the measurement of glomerular filtration rate.

  1982cited by this paper
• 13 – Kinetics of Apolipoprotein B in Normal and Hyperlipidemic Man: Review of Current Data

  1982cited by this paper
• Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

  1979cited by this paper
• Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.

  1978cited by this paper
• Selective extraction of human serum very low density apolipoproteins with organic solvents.

  1977cited by this paper
• The low-density lipoprotein pathway and its relation to atherosclerosis.

  1977cited by this paper
• Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.

  1975cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper
• The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia.

  1972cited by this paper
• National registry of long-term dialysis patients.

  1971cited by this paper
• Efficient Trace-labelling of Proteins with Iodine

  1958cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper
• The theory of tracer experiments with 131I-labelled plasma proteins.

  1957cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper

• Lipoproteins in chronic kidney disease: from bench to bedside.

  2021cites this paper
• Protein Carbamylation: Chemistry, Pathophysiological Involvement, and Biomarkers.

  2018cites this paper
• lipoprotein lipase expression in chronic renal failure Secondary hyperparathyroidism downregulates

  2016cites this paper
• Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis

  2016cites this paper
• Rôle de la carbamylation des protéines dans les complications de l’insuffisance rénale chronique

  2015cites this paper
• [Role of protein carbamylation in chronic kidney disease complications].

  2015cites this paper
• Humoral immune response to carbamyl-epitopes in atherosclerosis

  2014influential citation
• What is the Role of Lipid Measurements in End‐Stage Renal Disease?

  2014cites this paper
• The CKD Patient with Dyslipidemia

  2014cites this paper
• Chronic Increase of Urea Leads to Carbamylated Proteins Accumulation in Tissues in a Mouse Model of CKD

  2013cites this paper
• Carbamyl Adducts on Low-Density Lipoprotein Induce IgG Response in LDLR −/− Mice and Bind Plasma Autoantibodies in Humans Under Enhanced Carbamylation

  2013cites this paper
• Title Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP 1 expression

  2012cites this paper
• Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury.

  2012cites this paper
• Endothelial Function and the Kidney

  2012cites this paper
• New Insights into the Assembly and Metabolism of ApoB-Containing Lipoproteins from in vivo Kinetic Studies: Results on Healthy Subjects and Patients with Chronic Kidney Disease

  2012cites this paper
• Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression

  2011cites this paper
• Low-density lipoprotein (LDL) cholesterol is cross-sectionally associated with preclinical chronic kidney disease (CKD) in Japanese men.

  2010cites this paper
• Lipoprotein Metabolism Abnormalities in Patients with Chronic Renal Insufficiency

  2010cites this paper
• Low-density lipoprotein clearance in patients with chronic renal failure.

  2009influential citation
• Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs—apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes

  2009cites this paper
• Lipids in aging and chronic illness: impact on survival

  2008cites this paper
• CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Kinetic Studies of Atherogenic Lipoproteins in Hemodialysis Patients: Do They Tell Us More about Their Pathology?

  2007cites this paper
• The impact of haemodialysis-associated variables on lipid profile in Egyptian haemodialysis population

  2007cites this paper
• Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density

  2005cites this paper
• Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis

  2005cites this paper
• Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patients.

  2004cites this paper
• Lipoprotein lipase in hemodialysis patients and healthy controls : effects of heparin

  2004cites this paper
• Management of selected lipid abnormalities: hypertriglyceridemia, isolated low HDL-cholesterol, lipoprotein(a), and lipid abnormalities in renal diseases and following solid organ transplantation.

  2003cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE CIÊNCIAS MÉDICAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS MÉDICAS: NEFROLOGIA

  2003cites this paper
• LIPOPROTEIN METABOLISM ABNORMALITIES IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY

  2002cites this paper
• MANAGEMENT OF SELECTED LIPID ABNORMALITIES

  2001cites this paper
• Regulation of plasma low density lipoprotein levels in postmenopausal women.

  2000cites this paper
• Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation.

  2000cites this paper
• Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy.

  2000cites this paper
• Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia.

  1999cites this paper
• Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.

  1997cites this paper
• Endothelial function and the kidney. An emerging target for cardiovascular therapy.

  1997cites this paper
• Down-regulation of VLDL receptor expression in chronic experimental renal failure.

  1997cites this paper
• The role of oxidatively modified lipoproteins in lipid nephropathy.

  1997cites this paper
• Lipids in progression of renal disease.

  1997cites this paper
• Gene expression of LDL receptor, HMG-CoA reductase, and cholesterol-7 alpha-hydroxylase in chronic renal failure.

  1997cites this paper
• Low‐density lipoprotein subfraction profiles in dialysis patients

  1997cites this paper
• Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.

  1997cites this paper
• Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.

  1997cites this paper
• Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase.

  1997cites this paper
• Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure.

  1996cites this paper
• Lipoprotein (a) Levels in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

  1996cites this paper
• Prospective case control study to determine the effect of lovastatin on serum testosterone and cortisol concentrations in hyperlipidemic nephrotic patients with chronic renal failure.

  1996cites this paper
• Carbamylation of proteins and atherogenesis in renal failure.

  1995cites this paper
• Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment.

  1995cites this paper
• Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients.

  1994cites this paper